[Talc pleurodesis in recurrent malignant pleural effusion--a prospective follow-up study].
Talc pleurodesis was performed in a prospective trial in 38 patients with recurrent malignant pleural effusion. After insertion of a chest tube a slurry containing 8g of iodined talcum, 0.5 ml of 1% xylocain/kg/body weight, and 80 ml of 0.9% NaCl was administered and suction drainage was performed. The chest tube could be removed after 4 +/- 1.7 days. A successful therapy could be achieved in 33/38 patients (86.8%). 2 patients (5.3%) suffered from recurrent pleural effusion which only in 1 case had to be drained. 3 patients died within the first month after talc pleurodesis due to an advanced cancer stage. Complications did not come to evidence in any case.
Walter
M
M
Klinik und Poliklinik für Chirurgie, Universität zu Köln.
Türler
A
A
Schmitz-Rixen
T
T
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015505:Chest Tubes; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D016066:Pleural Effusion, Malignant / Q000401:mortality / Q000628:therapy*; D018700:Pleurodesis / Q000379:methods*; D011446:Prospective Studies; D012008:Recurrence; D015996:Survival Rate; D013627:Talc / Q000008:administration & dosage*
D013627:Talc